==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 1688308410.5144/0256-4947.2006.266asm-4-266Original ArticleHypertension control and co-morbidities in primary health care centers in Riyadh Al-Tuwijri Abdulmohsin A. *Al-Rukban Mohammed Othman † * Department of Family Medicine, Ministry of Health, Riyadh, Saudi Arabia † Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence and reprint requests: Mohammed Othman Al-Rukban, DPHC, ABFM, SBFM, Department of Family and Community Medicine, College of Medicine, King Saud University, P.O. Box 91678, Riyadh 11643, Kingdom of Saudi Arabia, Tel. +966-1-467 0836, Fax. +966-1-467 1967, mrukban@ksu.edu.saJul-Aug 2006 26 4 266 271 Copyright © 2006, Annals of Saudi Medicine2006This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.BACKGROUND The prevalence of hypertension in Saudi Arabia has been assessed only in preliminary reports. The aim of this study was to determine the degree of control of blood pressure and the prevalence of common hypertension co-morbidities among hypertensive patients attending primary healthcare (PHC) centers in Riyadh. METHODS A cross-sectional study was conducted by reviewing medical records of hypertensive patients during May and June 2001. Two hundred fifty-five medical records were selected by a stratified randomization process according to the distribution of the 73 PHC centers in the city and the total number of hypertensive patients registered in the mini-clinic of each PHC center. Trained mini-clinic nurses collected data using a data collection form developed for this purpose. RESULTS Of 255 patients, 121 (47.5%) were males and 134 (52.5%) were females; the mean age was 57.2±11.1 years and 8.3% were smokers. The majority, 204 (85.7%), had greater than normal body weight. Only 101 (40.4%) had controlled systolic BP and 129 (51.6%) had controlled diastolic BP. The most common co-morbidity was diabetes mellitus, found in 98 (38.4%), followed by dyslipidemia in 50 (19.6%), bronchial asthma in 28 (11.0%) and renal diseases in 12 (4.7%). Except for osteoporosis, which was reported by females only (P=0.003), the occurrence of hypertensive co-morbidities did not vary from other demographic characteristics. CONCLUSION This study demonstrated poor blood pressure control in the mini-clinics in PHC centers. To improve the quality of care for hypertensive patients, we recommend an improvement in PHC physician knowledge of and attitudes toward the importance of achieving targeted blood pressure levels. ==== Body Hypertension is a chronic condition and a major public health problem.1 It can adversely affect the health status of the individual, family and community and directly affects the quality of health and possibly of life in the general population. The prevalence of hypertension is a factor in determining the need for new health services.2 Raised blood pressure is mostly asymptomatic, but without being noticed produces a variety of structural changes in arteries that supply blood to the brain, heart, kidneys and elsewhere. 3 It is an expensive disease to treat, but a major modifiable risk factor for coronary heart disease (CHD), cerebrovascular accidents (CVA), congestive heart failure (CHF) and renal failure.4–7 The risk of cardiovascular disease depends on blood pressure, coexistent risk factors, and whether there is hypertensive damage to target organs.8 The prevalence of hypertension is increasing in many parts of the world. In Europe, it is 34.2% compared with 27.6% in North America.9–11 In Kuwait, the most recent data on hypertension showed a prevalence rate of 26.3%.12 In Qatar, a recent study showed that the prevalence of hypertension was 32.1%.13 In Egypt, a recent study showed that the prevalence of high normal blood pressure was 20.1% and hypertensive was 45.3%.14 In Oman, the prevalence rate of high systolic or diastolic blood pressure is 33%.15 The prevalence of hypertension in the Kingdom of Saudi Arabia has not been appropriately determined, but in some preliminary reports from the East, Central and West regions prevalence ranges between 5% to 30%.16–19 In a population-based survey to determine the prevalence of hypertension in the adult population in the different geographical regions of the Kingdom, the results showed that in the Riyadh region, the prevalence of systolic blood pressure (SBP) was 18% (19.2% in males and 17.3% in females); and diastolic blood pressure (DBP) was 22.1% (21.4% in males and 22.6% in females).20 At the primary health care (PHC) level, hypertension is frequently one of the most common reasons for patients to see primary care physicians.21 The overall rate of hypertension in PHC centers in Riyadh city was 15.4%. Of these, 11.3% were known hypertensive and 4.1% were newly diagnosed. About 27% of all hypertensive were not aware of their disease and more than 3l% of known hypertensives were apparently not well controlled.22 Although studies on the degree of control of hypertension in our community are few, the rate of BP control seems to be less than expected. This study was carried out to determine the prevalence of controlled blood pressure and common co-morbidities among hypertensive patients attending PHC centers in Riyadh. The PHC system in Saudi Arabia, which provides basic essential health care for individuals and families, was introduced in 1984.23 In Riyadh city, there are 73 PHC centers distributed into the five sectors of the city. The mini-clinic program was started in some centers to serve patients with chronic diseases, including diabetes mellitus, hypertension and bronchial asthma, with a regular monthly follow-up. Methods We conducted a cross sectional study by reviewing patient medical records during the months of May and June 2001. After permission from health authorities in Riyadh, one PHC center was selected randomly from each sector. Around 1800 hypertensive patients registered in the mini-clinics of those centers. Two hundred fifty-five medical records were selected by a stratified randomization process according to the total number of hypertensive patients registered in the mini-clinic of each PHC center. A sample size of 249 files was calculated on the assumption of a 25% prevalence of controlled BP and a degree of precision of 0.05 at the 95% level of confidence. Subjects were eligible for our study if they were adults, hypertensive, having regular follow-up visits at the mini-clinic and were seen at least once during the last 3 months prior to the study period. Subjects were excluded if they were 18 years of age or less, had missed 3 consecutive appointments, or were being followed in other health institutions (other clinics or hospitals). A data collection form was developed taking into consideration the opinions of an epidemiologist and biostatistician. The first part covered demographic data: age, sex, nationality, occupation and educational level. The second part concerned data on hypertension: date of diagnosis, date of first and last visit to the PHC center and last BP reading that categorized according to the international standards.24 The third part covered smoking and obesity (body mass index), both risk factors for hypertension.25 The fourth part covered co-morbidities of hypertension, including diabetes mellitus, bronchial asthma, cerebrovascular accidents, peripheral vascular diseases, angina, myocardial infarction, congestive heart failure, atrial fibrillation, conduction defects, liver diseases, renal diseases, dyslipidemia, gout, osteoporosis and depression. The results of a pilot study with 12 medical records were used to modify the data collection form. The final data collection form was distributed to data collectors in the selected centers. Trained mini-clinic nurses collected data. The researchers met with them and explained the aims and the methods of the study followed by a practical session on a sample of files. EPI-info software was used for data entry, management and analysis. Odds ratios with 95% confidence intervals and a chi-square or Fisher exact test were used for studying the associations between different variables at the 95% level of significance. Results This cross-sectional study included 255 medical records. The mean age of the participants was 57.2±11.1 years. Females constituted 52.5% of the sample. Most of the participants were Saudis (81%), many were housewives (45%), and about half were illiterate (52%) (Table 1). Twenty-one (8.3%) were smokers. The majority, 204 (85.7%), were above a normal weight. Morbid obesity (BMI ≥ 40) was seen in 22 (9.2%), while only 34 (14.3%) were in the normal BMI range (Table 2). The majority, 220 (87.3%), of hypertensive patients were diagnosed within 5 years and 169 (66.8%) began to be followed in the PHC centers less than 3 years prior to the study (Table 3). Unfortunately, only 101 (40.4%) had a controlled systolic BP (<140 mm Hg) and 129 (51.6%) had a controlled diastolic BP (<90 mm Hg) (Table 4). There was no significant statistical difference in the control of SBP or DBP between different primary health centers (PHC) (P>0.05). Diastolic blood pressure control was not affected by any demographic or co-morbidity factors (P>0.05) while systolic blood pressure control was only enhanced by the presence of dyslipidemia (P=0.023). The highest prevalence of hypertensive complications and co-morbidities in PHC centers was for diabetes 98 (38.4%), followed by dyslipidemia in 50 (19.6%), bronchial asthma in 28 (11.0%) and renal diseases in 12 (4.7%). No cases of atrial fibrillation or peripheral vascular disease were reported. All other complications and co-morbidities were not more than 4% for each one. Except for osteoporosis, which was reported only by females (P=0.003), the occurrence of hypertensive co-morbidities did not vary between different demographic factors. Discussion Unfortunately, 60% of hypertensive patients followed in PHC centers have uncontrolled SBP and 50% have uncontrolled DBP. A similar pattern was shown in another study in Saudi Arabia, where uncontrolled BP was 63% in males and 76% in females.17 A lower figure (28.8%) was reported by Al-Shammari et. al.26 These findings are also within the range of data reported in some international studies11,24,27,28 and much worse than the 20% reported by another international study.29 However, the Canada Heart Health Survey found that only 13% of Canadians with hypertension were adequately controlled.30 This result was even lower than the 25% found in the US National Health and Nutrition Examination Survey (NHANES III).31 The burden of elevated blood pressure as a risk factor for cardiovascular diseases, heart failure, cerebrovascular disease and renal failure in both men and women has been clarified in a large number of epidemiological studies,24,32,33 and there is evidence that patients with target organ damage associated with hypertension have a higher morbidity and mortality.12 A 20 mm Hg increase in DBP was associated with a 60% increased risk of death over a 2-year period.18 The inadequate control of hypertension not only has significant consequences in terms of patient morbidity and mortality but also in terms of health care costs.18 Studies on control of high blood pressure identified four barriers for successful control—lack of detection, lack of referral to care, lack of appropriate treatment and lack of long-term maintenance.18,34 Poor compliance with hypertensive therapy is thought to be a major factor in the failure to control hypertension.35 Locally, in one study from Tabuk, the compliance rate was as low as 53% and was accompanied by inadequate blood pressure control among non-compliant subjects.36 Another important reason for poor blood pressure control is a lack of updated information on how to manage hypertensive patients properly among physicians. Further improvements in hypertension control will require changes in physician behavior, which should be associated with awareness of practice guidelines and familiarity with evidence-based medicine methods.37 Multiple high quality long-term cohort studies and randomized clinical trails have shown that the risks from raised blood pressure can be partially reversed if an optimal blood pressure is achieved.8,11,24 However, a key factor associated with successful blood pressure control is the physician’s knowledge of and attitude towards the importance of achieving targeted blood pressure levels.21 Modification of lifestyle is also recommended in the management of individuals with hypertension so that normal blood pressure can be maintained, thereby reducing morbidity from stroke, myocardial infarction (MI), congestive heart failure and renal failure.24,35,38 Unfortunately, more than two thirds of the selected sample were overweight. The present study revealed a high association between hypertension and obesity. The same finding was reported worldwide.13,18,39–42 In general, weight gain in adults is a potent risk factor for the later development of many complications. The obese hypertensive patient is at a high risk for congestive heart failure and sudden death.43,44 Furthermore, several studies have shown that weight reduction in the obese hypertensive patient often reduces arterial blood pressure and produces cardiovascular changes.24,41,45–47 The prevalence of smoking among hypertensive patients observed in this study is less than what was reported in the eastern region of Saudi Arabia48 and in Qatar.13 The highest co-morbid conditions were diabetes mellitus followed by dyslipidemia and bronchial asthma. Around 40% of hypertensive patients in this study were diabetics, a prevalence equal to that in another local study27 and a similar study from Sudan,49 but less than that observed in Qatar13 (68.9%) and more than that reported by another national study (22.2%).48 It was found that aggressive reduction of blood pressure of diabetic patients will lead to reduced rates and progression of renal and cardiovascular diseases.50,51 The target blood pressure for hypertensive diabetic patients is <130/80, especially if the patient has microalbuminuria or macroalbuminuria.24,42,51 The level of blood pressure and presence of other risk factors and co-morbidities have long been recognized as a determinant of the risks for several common cardiovascular diseases, including coronary heart disease, cerebrovascular disease, heart failure and renal failure.3,52 For instance, the presence of smoking, high cholesterol, diabetes and hypertension combined increase the risk of vascular events by 20 times.53,54 The objective of hypertension care is to reduce its mortality and complications and to improve the quality of life for patients suffering from this chronic health problem. To achieve these aims, it is mandatory to have adequate diagnostic, therapeutic and educational resources in addition to competent physicians who can manage hypertension by using a continuing, comprehensive and coordinated approach.55 Management of hypertension in PHC centers is highly affected by lack of resources and facilities. Many essential resources for the care of patients with hypertension are not available at PHC settings.56 Urgent provision of these resources is essential to introduce good health care for hypertensive patients. To improve the quality of care for hypertensive patients and to ensure better control, we recommend improvements in PHC physician knowledge about chronic disease management, updating the national guidelines for management of hypertension and keeping them accessible to doctors in PHC clinics, improving the quality of the filing system, improvement of screening programs and the provision of essential resources for hypertension care. Further research to determine the underling reasons for inappropriate blood pressure control and the cost of blood pressure control are also recommended. We would like to thank Dr. Ahmed Al-Taweel for his assistance and support; also our thanks and appreciation to Dr. Ashry Gad Mohammed, Dr. Abdulelah Kutbi, Dr. Elijah Bamgboye and Dr. Mohammed Mahdi Balla for their helpful comments on earlier drafts and to Mr. Hasan who helped with the analysis. Table 1 Demographic characteristics of hypertensive patients in primary healthcare centers in Riyadh, 2001. Characteristic N % Age (n = 254) (years) <65 185 72.8 >65 69 27.2 Sex (n = 255) Male 121 47.5 Female 134 52.5 Nationality (n=255) Saudi 206 80.8 Non-Saudi 49 19.2 Occupational Status (n = 254) Professional 37 14.6 Technical 13 5.1 Manual 5 2.0 Retired 47 18.5 Housewife 114 44.9 Others 38 18.4 Educational level (n = 245) Illiterate 128 52.2 Primary 45 18.4 Intermediate 25 10.2 Secondary 27 11.0 University 20 8.2 Table 2 Body weight and smoking among hypertensive patients followed in primary healthcare centers in Riyadh, 2001. Risk Factor N % BMI (n = 238) Normal weight (<25 kg/m2) 34 14.3 Overweight (25–29.9 kg/m2) 84 35.3 Obese (Class I & II) (30–39.9 kg/m2) 98 41.2 Morbidly obese (≥40 kg/m2) 22 9.2 Smoking (n = 252) Yes 21 8.3 No 231 91.7 Table 3 History of hypertension among hypertensive patients followed in primary healthcare centers in Riyadh, 2001. Past Medical History N % Date of diagnosis (years) (n = 252) <1 33 13.1 1–5 187 74.2 >5–10 13 6.2 >10–15 17 6.8 >15 2 0.8 Date of first visit to PHC center (years) (n = 253) <1 29 11.5 1–2 36 14.2 >2–3 104 41.1 >3–4 34 13.4 >4–5 18 7.1 >5 32 12.6 Table 4 Blood pressure control among hypertensive patients followed in PHC centers in Riyadh, 2001. Blood Pressure Level N % Systolic (mm Hg) (n = 250) 140–159 91 36.4 ≥160 58 23.2 Uncontrolled (≥140) 149 59.6 Diastolic (mm Hg) (n = 250) 90–99 76 30.4 ≥100 45 18.0 Uncontrolled (≥90) 121 48.4 ==== Refs References 1 Aminoff UB Kjellgren KI The nurse-a resource in hypertension care J Adv Nurs 2001 35 4 582 9 11529958 2 Hashim TJ Anokute CC AI-Shammnary FJ Khoja TA Saeed AA Khan SB Hypertension awareness: treatment and control among adult hypertensives Saudi Med J 1998 19 6 707 12 3 World Health Organization Other diet related risk factors and physical inactivity The World Health Report, Reducing risks, promoting health life 2002 4 Medical Research Council Working Party MRC trial of treatment of mild hypertension: principal results BMJ 1985 291 97 104 2861880 5 Collins R Peto R MacMohan S Herbert P Fieback NH Eberlein KA Blood pressure, stroke and coronary heart disease-Part 2. Short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context Lancet 1990 335 827 38 1969567 6 Veterance Administration Co-operation Study Group on Anti-Hypertension Agents Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mm hg JAMA 1967 202 1028 34 4862069 7 MacMohan S Peto R Cutler J Collins R Sor Pie P Neaton J BP, Stroke & CHD: part 1, prolonged differences in BP: prospected observational studies corrected for the regression dilution bias Lancet 1990 335 765 74 1969518 8 Padwal R Straus SE McAlister Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review BMJ 2001 322 977 80 11312234 9 Wolf-Maier K Cooper RS Banegas JR Giampaoli S Hense HW Joffer M Hypertension, prevalence and blood pressure levels in 6 European countries, Canada, and the United States JAMA 2003 289 18 2363 9 12746359 10 Nazim K Prevalence of hypertension in Saudi Arabia The Practitioner, East Mediterranean Edition 1994 5 805 6 11 Konzem SL Devore VS Bauer DW Controlling Hypertension in Patients with Diabetes Am Fam Physician 2002 66 1209 14 12387432 12 Al-Duwaisan HS Al-Mehza AM Al-Yaha AA Al-Qattan MM Assessment of target organ damage in hypertension through a clinical audit in Kuwait family practice Kuwait Medical Journal 2003 35 3 202 7 13 Bener A Al-Suwaidi J Al-Jaber K Al-Marri S Dogash MH Elbagi IA The prevalence of hypertension and its associated risk factors in a newly developed country Saudi Med J 2004 25 7 918 22 15235700 14 Ibrahim MM Appel LJ Rizk HH Helmy S Mosley J Ashour Z Cardiovascular risk factors in normotensive and hypertensive Egyptians J Hypertens 2001 19 11 1933 40 11677357 15 Annual health reports Morbidity and mortality rate Ministry of Health Sultanate of Oman 2002 16 AL-Khashman AS Screening for Hypertension: Assessing the knowledge, attitudes and practice of primary health care physicians in Riyadh, Saudi Arabia Saudi Med J 2001 22 12 1096 100 11802184 17 Siddiqui S Ogbeide DO Karim A Al-Khalifa I Hypertension control in a community health centre at Riyadh, Saudi Arabia Saudi Med J 2001 22 1 49 52 11255611 18 Kalantan KA Mohamed AG Al-Taweel AA Abdulghani HM Hypertension among attendants of primary health care centers in Al-Qassim region, Saudi Arabia Saudi Med J 2001 22 11 960 3 11744965 19 Soyannwo MA Gadallah M Hams J Kurashi NY el-Essawi O Khan NA Some aspects of the pattern of systemic hypertension in the adult population of Gassim, Saudi Arabia: age distribution of the subsets of hypertensives Afr J Med Med Sci 1998 27 1–2 17 21 10456123 20 A1-Nozha MM Osman AK The prevalence of hypertension in different geographical regions of Saudi Arabia Ann Saudi Med 1998 18 5 401 7 17344710 21 Bernard DB Townsend RR Sylvestri MF Health and disease management: what is it and where is it going? What is the role of health and disease management in hypertension? Am J Hypertens 1998 11 8 Pt 2 103S 111S 22 Wahid SA Al Shammary FJ Khoja TA Hashini TJ Anokute CC Khan SB The prevalence of hypertension and sociodemographic characteristics of adult hypertensives in Riyadh city, Saudi Arabia J Hum Hypertension 1996 10 583 7 23 Khoja TA Salem A Primary Health Care: History and Future Minstery of Health 1st edt 2001 Al-Farzdaq Publication 12 24 Chobanian AV Bakris GL Black HR Cushman WC Green LE Izzo JL The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JAMA 2003 289 2560 72 12748199 25 Word Health Organization Obesity epidemic puts millions at risk from related diseases WHO/46 Geneva WHO 1997 26 Al-Shammari SA Nass M Al-Maatouq MA Al-Quaiz JM Family practice in Saudi Arabia: chronic morbidity and quality of care Int J Qual Health Care 1996 8 4 383 7 8938500 27 Akbar DH Al-Ghamdi AA Is hypertension well controlled in hypertensive diabetics Saudi Med J 2003 24 4 356 60 12754533 28 Chockalingam A Bacher M Campbell N Cutler H Drover A Feldman R Adherence to management of high blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control Can J Public Health 1998 89 I5 I11 9813919 29 Birtwhistle RV Godwin MS Delva MD Casson RI Lam M MacDonald SE Randomized equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners BMJ 2004 328 204 14726370 30 Joffres MR Hamet P MacLean DR L’italien GL Fodor G Distribution of blood pressure and hypertension in Canada and the United States AJH 2001 14 1099 105 11724207 31 Burt VL Cutler JA Higgins M Horan MJ Labarthe D Whelton P Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991 Hypertension 1995 26 60 9 7607734 32 Elisaf M The treatment of coronary heart disease: an update. Part 1: An overview of the risk factors for cardiovascular disease Curr Med Res Opin 2001 17 1 18 26 11464441 33 Black HR The burden of cardiovascular disease: following the link from hypertension to myocardial infarction and heart failure Am J Hypertens 2003 16 9 Pt 2 4S 6S 14511895 34 Guibert R Franco ED Choosing a definition of hypertension: impact on epidemiological estimates J Hypertens 1996 14 1275 80 8934354 35 McIntyre H Costa FV Dusing R Ambrosioni E Gerth W The role of losartan in cost-effective hypertension control Curr Med Res Opin 2002 18 3 139 45 12094823 36 Khalil SA Elzubier AG Drug compliance among hypertensive patients in Tabuk, Saudi Arabia J Hypertens 1997 15 5 561 5 9170010 37 Hyman DJ Pavlik VN Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine Arch Intern Med 2000 160 15 2281 6 10927724 38 Briganti EM Shaw JE Chadban SJ Zimmet PZ Welborn TA McNeil JJ Untreated hypertension among Australian adults: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) Med J Aust 2003 179 3 135 9 12885281 39 El-Hazmi MA Warsy AS Prevalence of hypertension in obese and non-obese Saudis Saudi Med J 2001 22 1 44 8 11255610 40 Gupta R Guptha S Gupta VP Prakash H Prevalence and determinants of hypertension in the urban population of Jaipur in Western India J Hypertens 1995 13 1193 200 8586811 41 Dyer AR Elliot P The INTERSALT study: relations of body mass index to blood pressure J Hum Hypertens 1989 3 299 308 2810326 42 Saudi Hypertension Management Group Saudi hypertension management guidelines, 2004 Riyadh 2004 43 Dustan HP Mechanisms of hypertension associated with obesity Ann Intern Med 1983 98 860 4 6342497 44 Licata G Scaglione R Dominguez LJ Early markers of cardiovascular damage in obese subjects Nutr Metab Cardiovasc Dis 1999 9 78 86 10726113 45 Huang Z Reddy A Weight change, ideal weight and hypertension Curr Opin Nephrol Hypertens 1999 8 343 6 10456266 46 Kaplan NM Obesity in hypertension: effects on prognosis and treatment J Hypertens Suppl 1998 16 S35 7 47 Reisin E Frohlich ED Messerli FH Dreslinski GR Dunn FG Jones MM Cardiovascular changes after weight reduction in obesity hypertension Ann Intern Med 1983 98 315 9 6338789 48 Al-Mustafa BA Abulrahi HA The role of primary health care centers in managing hypertension. How far are they involved? Saudi Med J 2003 24 5 460 5 12847618 49 Kheir MM Ahmed AM Elbalaa A Hypertension in type 2 diabetic patients Saudi Med J 2003 24 6 690 1 12847611 50 Eastman RC Ken H The impact of cardiovascular disease on patient with diabetes Lancet 1997 350 Suppl 1 29 32 51 Watkins PJ ABC of diabetes: Cardiovascular disease, hypertension, and lipids BMJ 2003 326 874 6 12702626 52 MacMahon S Blood pressure and the risk of cardiovascular disease N Engl J Med 2000 342 1 50 2 10620650 53 Ball SG Benefits of blood pressure reduction in diabetic patients J Hypertens 2003 21 Suppl 6 S31 6 54 Al-Yahya AA Al-Duwaisan HS Al-Mehza AM Improving the diagnosis of hypertension and assessment of vascular risk factors through a clinical audit in Kuwait family practice Kuwait Medical Journal 2003 35 2 105 10 55 Sloane PD Slatt LM Curtis P Essentials of Family Medicine 2nd ed Baltimore (MD) Williams & Wilkins 1993 245 51 56 Al-Sharif AI Al-Khaldi YM Resource availability for care of hypertensives at primary health settings in Southwestern Saudi Arabia Saudi Med J 2003 24 5 466 71 12847619